John Lavelle
Publication Details
-
The long-term cost effectiveness of treatments for benign prostatic hyperplasia.
Pharmacoeconomics. 2006; (2): 171-91
Excellent treatment outcomes with long-term durability and few adverse effects are expectations of treatments for chronic conditions. The long-term cost effectiveness of newer treatments for benign prostatic hyperplasia (BPH), including high-energy transurethral microwave thermotherapy (TUMT) and combination pharmaceutical therapy, has not been sufficiently studied against existing alternatives. The objective of this study was to estimate the incremental cost effectiveness of BPH treatment alternatives.
Help